In several collaborations, scientists at Orion and
Orion plans to develop tests that detect trace amounts of methylated tumor DNA in tissues such as blood serum, biopsies, and cell scraps, and expects to market them within three years.
In several collaborations, scientists at Orion and
Orion plans to develop tests that detect trace amounts of methylated tumor DNA in tissues such as blood serum, biopsies, and cell scraps, and expects to market them within three years.